Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Ventyx Biosciences Inc (VTYX)
Ventyx Biosciences Inc (VTYX) Financials

VTYX Ventyx Biosciences Inc

2.20

0.14 (6.80%)

Pre Market

Last Updated: 10:26:50

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-2479.656	-9486.195	-58.478	-32.714	-59.456
Return on Equity (%)	209.641	162.003	-68.638	-34.253	-64.555
Return on Invested Capital (%)	2964.539	77.096	-57.641	-39.969	-74.553
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	-0.224	-1.556	5.539	6.211	4.131
Earnings Per Share	-0.235	-1.43	-1.692	-1.903	-3.268
Cash Per Share	0.017	0.012	1.404	1.138	0.874
Working Capital Per Share	-0.015	-0.059	4.974	5.516	4.1
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-0.235	-1.43	-1.661	-1.903	-3.268
EBITDA Per Share	-0.235	-1.43	-1.661	-1.903	-3.268
Free Cash Flow Per Share	-0.235	-1.43	-1.688	-1.9	-3.262

Liquidity Ratios

Year End 31 December 2023	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	18.43M	19.7M	50.41M	56.98M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	56.63M	56.98M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	145.66M
Price to Earnings Ratio	-0.75
Price to Sales Ratio	0
Price to Cash Ratio	2.82
Price to Book Ratio	0.6
Dividend Yield	-

Share Statistics

Shares Outstanding	70.71M
Average Volume (1 week)	1.83M
Average Volume (1 Month)	1.31M
52 Week Change	-9.47%
52 Week High	11.48
52 Week Low	1.67

More Ratios Coming Soon!

Ventyx Biosciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions